Patrick Horsman, CFA
Managing Partner @ Horsman Holdings
San Juan, Puerto Rico
Patrick Horsman, CFA is a serial entrepreneur and investor. His focus is uncovering niche, esoteric investments that have a sustainable competitive advantage. Mr. Horsman is the Managing Partner and Co-Founder of Coral Capital an investment platform focused on DeFi and Crypto strategies. In 2002 he Co-Founded Blue Sand Securities, a placement agentthat has raised over $15B from institutional investors for Alternative Investment funds. He was also the COO and Co-Founder of Merion Investment Management a Litigation Finance fund he launched in 2009 with peak AUM of $1.2B. He is the Founder and CIO of Esoteric Strategies LP a hedge fund focused on investments in niche, uncorrelated strategies. He is also the Co-Founder of Innovation Shares, a thematic ETF index sponsor that offers investors exposure to cutting edge themes created using AI and Natural Language Processing, including NYSE: KOIN one of the first Blockchain ETF’s, and NYSE: THCX one of the first Cannabis ETF's. He is also a Co-Founder and Managing Partner of Integrated Ag, a private equity fund focused on Agricultural Investments in US Farmland with a specific focus on improving water infrastructure. He was also the Co-Founder and CEO of Integrated CBD, an institutional scale grower of Industrial Hemp, and refiner of CBD Oil. He is also the Founder of Verified Organic an Ethereum-based Blockchain application designed to bring transparency and accountability to the organic food production process from farm to table. He was a seed investor in Context Summits a hedge fund conference series focused on one on one meetings between institutional investors and hedge fund managers. He was previously the Founder and Managing Partner of Cypress Settlements a Fin-tech company that allowed institutional investors to electronically claim class action settlements from historical trading. Cypress was acquired by FRT in 2015. Mr. Horsman is the Managing Partner of Horsman Holdings a single family office that invests in Alternatives. Mr. Horsman resides in San Juan, PR and is an avid golfer and spear fisherman.
- Total investments:
- 1
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Patrick Horsman, CFA invests in
Stages Patrick Horsman, CFA invests in
Countries Patrick Horsman, CFA invests in
Investment Focus
Industry
- Wellness 1 (100%)
- Health Care 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Windtree Therapeutics (formerly Discovery Laboratories) is a clinical-stage biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Windtree proprietary technology platform includes a synthetic, peptide-containing surfactant (KL4 surfactant) that is structurally similar toendogenous pulmonary surfactant — and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree is focused initially on improving the management of respiratory distress syndrome (RDS) in premature infants and believes that its proprietary technology may make it possible, over time, to develop a pipeline of KL4 surfactant product candidates to address a variety of respiratory diseases for which there are few or no approved therapies. | $580M / Post-IPO Equity |
About Horsman Holdings
Horsman Holdings Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Patrick Horsman, CFA
Managing Partner
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Patrick Horsman, CFA invest in?
Patrick Horsman, CFA invests primarily in Wellness, Health Care and Biotechnology startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!